| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216568 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 10 Pages |
Abstract
Precision hypofractionated radiation therapy consisting of 60Â Gy in 15 fractions for locally advanced NSCLC is generally well tolerated. This treatment regimen could provide patients with poor performance status a potent alternative to chemoradiation. This study has implications for the cost effectiveness of lung cancer therapy. Additional studies of long-term safety and efficacy of this therapy are warranted.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kenneth D. MD, PhD, Billy W. MD, PhD, David E. MD, Puneeth MD, PhD, Hak MD, Maximilian MD, PhD, Randy MD, Joan MD, Jonathan MD, Zabi MD, David MD, MPH, Alana MS, Xian-Jin PhD, Irma Corona, Akanksha Sharma, Margaret E. MD, Robert MD,